GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Scaled Net Operating Assets

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Scaled Net Operating Assets : 0.40 (As of Aug. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Newbury Pharmaceuticals AB's operating assets for the quarter that ended in Aug. 2024 was kr75.57 Mil. Newbury Pharmaceuticals AB's operating liabilities for the quarter that ended in Aug. 2024 was kr38.95 Mil. Newbury Pharmaceuticals AB's Total Assets for the quarter that ended in May. 2024 was kr90.76 Mil. Therefore, Newbury Pharmaceuticals AB's scaled net operating assets (SNOA) for the quarter that ended in Aug. 2024 was 0.40.


Newbury Pharmaceuticals AB Scaled Net Operating Assets Historical Data

The historical data trend for Newbury Pharmaceuticals AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB Scaled Net Operating Assets Chart

Newbury Pharmaceuticals AB Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Scaled Net Operating Assets
0.59 0.83 0.47 0.50

Newbury Pharmaceuticals AB Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.41 0.37 0.41 0.40

Competitive Comparison of Newbury Pharmaceuticals AB's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Newbury Pharmaceuticals AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Newbury Pharmaceuticals AB's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Newbury Pharmaceuticals AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Newbury Pharmaceuticals AB's Scaled Net Operating Assets falls into.



Newbury Pharmaceuticals AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Newbury Pharmaceuticals AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Aug. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Aug. 2024 )
=(Operating Assets (A: Aug. 2024 )-Operating Liabilities (A: Aug. 2024 ))/Total Assets (A: Aug. 2023 )
=(75.568-38.954)/72.918
=0.50

where

Operating Assets(A: Aug. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=90.871 - 15.303
=75.568

Operating Liabilities(A: Aug. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=38.954 - 0 - 0
=38.954

Newbury Pharmaceuticals AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Aug. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Aug. 2024 )
=(Operating Assets (Q: Aug. 2024 )-Operating Liabilities (Q: Aug. 2024 ))/Total Assets (Q: May. 2024 )
=(75.568-38.954)/90.761
=0.40

where

Operating Assets(Q: Aug. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=90.871 - 15.303
=75.568

Operating Liabilities(Q: Aug. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=38.954 - 0 - 0
=38.954

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Newbury Pharmaceuticals AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Newbury Pharmaceuticals AB Business Description

Traded in Other Exchanges
N/A
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB Headlines

No Headlines